Skip to main content
. 2021 Jun 16;373:n1332. doi: 10.1136/bmj.n1332

Fig 1.

Fig 1

Hazard ratios for individual trials and for pooled population and Kaplan-Meier estimates for primary endpoint of all cause death, myocardial infarction, or stroke in intention to treat population. Kaplan-Meier curves and hazard ratios from one step, fixed effect meta-analysis (top) and two step, fixed effect meta-analysis (bottom). DAPT=dual antiplatelet therapy; P2Y12i=P2Y12 inhibitor monotherapy